SHANGHAI, June 17, 2024 /PRNewswire/ -- MicroPort® CardioFlow Medtech Corporation (CardioFlow) (Stock Code: 02160.HK) recently announced that its self-developed second-generation transcatheter aortic ...

MicroPort® CardioFlow Medtech Corporation (CardioFlow) (Stock Code: 02160.HK) recently announced that its self-developed second-generation transcatheter aortic valve implantation (TAVI) device, the ...

The latest update is out from MicroPort CardioFlow Medtech Corp. ( (HK:2160)). MicroPort CardioFlow Medtech Corporation announced that its VitaFlow series TAVI systems have now been introduced in 35 ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks MicroPort CardioFlow Medtech Corp.

This certification highlights VitaFlow Liberty ™ as a pioneering TAVI solution, that sets a new benchmark in transcatheter heart valve treatments. With over 47 million patients globally [1] suffering ...

suffering from aortic valve stenosis and regurgitation, the prevalence rates of these conditions are on the rise due to an aging population. The TAVI solution provided by CardioFlow, which avoids open ...